Analystreport

Neos Therapeutics, Inc. (NASDAQ: NEOS) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.

NEOS THERAPEUTICS  (NEOS) 
Last neos therapeutics earnings: 8/8 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: neostx.com